Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Ironwood Pharmaceuticals

WKN: A0X789 / Symbol: IRWD / Name: Ironwood Pharms / Stock / Biotechnology & Medical Research / Mid Cap /

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top EstimatesPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Ironwood Pharmaceuticals (IRWD) Q2 Earnings Top Estimates

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.14 per share a year ago

0

Ironwood Pharmaceuticals Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens, Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png

Ironwood Pharmaceuticals Q2 Earnings Call Highlights

Key Points

Interested in Ironwood Pharmaceuticals, Inc.? Here are five stocks we like better.

LINZESS sales strengthened: U.S. second-quarter sales rose 14% to $282.3 million, prompting

0

Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View RaisedPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised

Ironwood Pharmaceuticals IRWD reported adjusted earnings of 31 cents per share for the second quarter of 2026, surpassing the Zacks Consensus Estimate of 26 cents. The company had reported adjusted

0

Inovio Pharma

WKN: A115GK / Symbol: INO / Name: Inovio Pharma / Stock / Biotechnology & Medical Research / Small Cap /

Innate Pharma

WKN: A0LCUJ / Name: Innate Pharma / Stock / Biotechnology & Medical Research / Small Cap /

4d Pharma plc

WKN: A1XD45 / Name: 4D Pharma / Stock / Biotechnology & Medical Research / Small Cap /

aTyr Pharma Inc

WKN: A2PM86 / Name: aTyr Pharma / Stock / Biotechnology & Medical Research / Micro Cap /

ESSA Pharma Inc

WKN: A2JKQ4 / Name: ESSA / Stock / Biotechnology & Medical Research / Micro Cap /

FSD Pharma Inc

WKN: A2JM6M / Name: FSD Pharma / Stock / ? /

Innate Pharma S.a.

WKN: A2PSSH / Name: Innate Pharma S.a. / Stock / ? /

N4 Pharma

WKN: A2DQES / Name: N4 Pharma / Stock / Leisure Products / Micro Cap /

Odi Pharma Ab

WKN: A2PXH6 / Name: Odi Pharma Ab / Stock / ? /

Eql Pharma Ab

WKN: A12AZY / Name: Eql Pharma Ab / Stock / ? /

Pila Pharma Ab

WKN: A3CT5N / Name: Pila Pharma Ab / Stock / ? /

Evoke Pharma Inc.

WKN: A3DL9U / Symbol: EVOK / Name: Evoke Pharma / Stock / Pharmaceuticals / Micro Cap /

MEI Pharma Inc.

WKN: A3D69W / Symbol: MEIP / Name: MEI Pharma / Stock / Biotechnology & Medical Research / Small Cap /

Acasti Pharma Inc.

WKN: A3EP78 / Name: Acasti Pharma / Stock / Pharmaceuticals / Micro Cap /

Traws Pharma Inc.

WKN: A40PJ7 / Name: Traws Pharma Inc. / Stock / ? /